Nature Reviews Cancer presents a Collection on Biomarkers, which includes recent Research Highlights, Reviews and Perspectives from the journal. Biomarkers are invaluable tools for cancer detection, diagnosis, patient prognosis and treatment selection. The articles presented here highlight the importance of cancer biomarkers and discuss the issues surrounding their use and development. The articles are freely available until 30 November 2007.
Research Highlights
Taking out the trash
Kristine Novak
doi:10.1038/nrc1807
Nature Reviews Cancer 6, 92 (2006)
Small but influential
Ezzie Hutchinson
doi:10.1038/nrc1896
Nature Reviews Cancer 6, 345 (2006)
Prognostic proteasome
Edward Wawrzynczak
doi:10.1038/nrc2057
Nature Reviews Cancer 7, 6-7 (2007)
Reviews
Common markers of proliferation
Michael L. Whitfield, Lacy K. George, Gavin D. Grant & Charles M. Perou
doi:10.1038/nrc1802
Nature Reviews Cancer 6, 99-106 (2006)
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Cornelia M. Ulrich, Jeannette Bigler & John D. Potter
doi:10.1038/nrc1801
Nature Reviews Cancer 6, 130-140 (2006)
Predicting benefit from anti-angiogenic agents in malignancy
Adrian M. Jubb, Adam J. Oates, Scott Holden & Hartmut Koeppen
doi:10.1038/nrc1946
Nature Reviews Cancer 6, 626-635 (2006)
Perspectives
The blood peptidome: a higher dimension of information content for cancer biomarker discovery
Emanuel F. Petricoin, Claudio Belluco, Robyn P. Araujo & Lance A. Liotta
doi:10.1038/nrc2011
Nature Reviews Cancer 6, 961-967 (2006)
The US Food and Drug Administration perspective on cancer biomarker development
Steven Gutman & Larry G. Kessler
doi:10.1038/nrc1911
Nature Reviews Cancer 6, 565-571 (2006)
